MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$103,848,000
(-61.58%↓ Y/Y)
Net loss
-$102,302,000
(-57.27%↓ Y/Y)
Unrealized gain (loss) on
available-for-sale securities...
-$1,546,000
(-299.23%↓ Y/Y)
Income tax recovery
(expense)
-$2,571,000
(-702.11%↓ Y/Y)
Interest income
$6,907,000
(-14.55%↓ Y/Y)
Foreign exchange loss
$548,000
(1465.71%↑ Y/Y)
Loss before income
taxes
-$104,873,000
(-62.29%↓ Y/Y)
Total other income
$7,455,000
(-8.17%↓ Y/Y)
Loss from operations
-$112,328,000
(-54.43%↓ Y/Y)
Total operating
expenses
$112,328,000
(39.99%↑ Y/Y)
Research and development
$88,508,000
(44.62%↑ Y/Y)
General and
administrative
$23,820,000
(25.12%↑ Y/Y)
Back
Back
Income Statement
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)
logo_icon_teal_2280px-svg
source: myfinsight.com
Xenon Pharmaceuticals Inc. (XENE)